CDK1 and neoplasm: Regarding cell cycle markers, SNHG4 silencing increased, whereas miR-590-3p inhibition decreased, the protein levels of CDK1, cyclinB1, and cyclinA2 in the tumor samples; the effects of SNHG4 silencing on cell cycle markers were also significantly reversed by miR-590-3p inhibition (Figure 8D).